Real-world experience with relugolix. This is an ASCO Meeting Abstract from the 2022 ASCO Genitourinary Cancers Symposium. This abstract does not include a full text component.
Comprehensive care for prostate cancer (PCa) patients extends well beyond selecting therapies based on available guidelines. Patients should be supported to understand the disease, diagnostics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback